Ken Valenzano - Net Worth and Insider Trading
Ken Valenzano Net Worth
The estimated net worth of Ken Valenzano is at least $284,622 dollars as of 2024-04-29. Ken Valenzano is the SVP, Pharmacology & Biology of Amicus Therapeutics Inc and owns about 27,687 shares of Amicus Therapeutics Inc (FOLD) stock worth over $284,622. Details can be seen in Ken Valenzano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ken Valenzano has not made any transactions after 2015-07-13 and currently still holds the listed stock(s).
Transaction Summary of Ken Valenzano
Ken Valenzano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ken Valenzano owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of Ken Valenzano’s form 4 insider trades.
Insider Ownership Summary of Ken Valenzano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-07-13 | VP & Pharmacology & Biology |
Ken Valenzano Latest Holdings Summary
Ken Valenzano currently owns a total of 1 stock. Ken Valenzano owns 27,687 shares of Amicus Therapeutics Inc (FOLD) as of July 13, 2015, with a value of $284,622.
Latest Holdings of Ken Valenzano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-07-13 | 27,687 | 10.28 | 284,622 |
Holding Weightings of Ken Valenzano
Ken Valenzano Form 4 Trading Tracker
According to the SEC Form 4 filings, Ken Valenzano has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 15,000 shares on July 13, 2015, which brought Ken Valenzano around $225,000.
Insider Trading History of Ken Valenzano
- 1
Ken Valenzano Trading Performance
Ken Valenzano Ownership Network
Ownership Network List of Ken Valenzano
Ownership Network Relation of Ken Valenzano
Ken Valenzano Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Ken Valenzano is the VP & Pharmacology & Biology of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Ken Valenzano made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 645,546 shares made by John F Crowley , a net sale of 258,416 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 185,169 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 185,169 shares. During the past 18 months, 1,242,298 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,242,298 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Ken Valenzano Mailing Address
Above is the net worth, insider trading, and ownership report for Ken Valenzano. You might contact Ken Valenzano via mailing address: 6 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
